Cites del registre
Cita APA (7th ed.)
Kater, A., Dubois, J., Brieghel, C., Kersting, S., Enggaard, L., Veldhuis, G., . . . Niemann, C. (2023). S148: TIME-LIMITED VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CLL WHO HAVE UNDETECTABLE MRD – 4-YEAR FOLLOW UP FROM THE RANDOMIZED PHASE II VISION/HO141 TRIAL. Wiley.
Copiat
No s'ha pogut copiar
Cita Chicago (17th ed.)
Kater, Arnon, et al. S148: TIME-LIMITED VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CLL WHO HAVE UNDETECTABLE MRD – 4-YEAR FOLLOW UP FROM THE RANDOMIZED PHASE II VISION/HO141 TRIAL. Wiley, 2023.
Copiat
No s'ha pogut copiar
Cita MLA (9th ed.)
Kater, Arnon, et al. S148: TIME-LIMITED VENETOCLAX AND IBRUTINIB FOR PATIENTS WITH RELAPSED/REFRACTORY CLL WHO HAVE UNDETECTABLE MRD – 4-YEAR FOLLOW UP FROM THE RANDOMIZED PHASE II VISION/HO141 TRIAL. Wiley, 2023.
Copiat
No s'ha pogut copiar
Atenció: Aquestes cites poden no estar 100% correctes.